INTERMEDIATE UVEITIS AS THE FIRST PRESENTATION OF MULTIPLE SCLEROSIS
Intermediate uveitis is a chronic, relapsing disease of insidious onset in which according to the SUN Working Group, the vitreous is the primary site of inflammation as determined clinically. Intermediate uveitis associated with systemic disease has variable course. Multiple sclerosis is associated with intermediate uveitis. We report a case of multiple sclerosis were intermediate uveitis was the first presentation of the disease. A 33-year-old man with a 5 months history of decreased vision in his right eye. Best-corrected visual acuity was 0.6 on his right eye and 1.0 on his left eye. Intraocular pressure was 17 mmHg and 15 mmHg on the right and left respectively. He had no signs of ocular surface inflammation, cornea clear, AC without signs of inflammation, lens clear. Right eye 3+ vitreous cells and vitreous condensations left eye 1+vitreous cells. Right eye fundus showed hyperemia of optic nerve head, irregular reflexes in the macula, peripheral retina without signs of retinitis or vasculitis. Left eye fundus showed only optic nerve head slightly hyperaemic. OCT, Indocyanine Green Angiography and fluorescein angiography were performed. We performed the investigations for diagnosing uveitis (angiotensin converting enzyme, serology for Treponema pallidum, Borrelia burgdorferi, Mantoux, neurological investigation) and all turned out to be negative except of MRI Brain and Spine that revealed multiple T2 hyperintense lesions consistent with multiple sclerosis. Multiple sclerosis may present initially with an intermediate uveitis. Multiple sclerosis should be suspected in patients aged 20-50 even without any neurological symptoms, noting that intermediate uveitis may precede other symptoms of demyelination.
Key words: intermediate uveitis, multiple sclerosis, vitritis
2. Rizzo JF, 3rd, Lessell S. Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long-term
prospective study. Neurology. 1988;38(2):185–90.
3. Nerrant E, Tilikete C. Ocular motor manifestations of multiple sclerosis. J Neuroophthalmol. 2017;37(3):332–40.
4. Tilikete C, Jasse L, Vukusic S, et al. Persistent ocular motor manifestations and related visual consequences in
multiple sclerosis. Ann N Y Acad Sci. 2011;1233:327-34.
5. Winges KM, Werner JS, Harvey DJ, et al. Baseline retinal nerve fiber layer thickness and macular volume
quantified by OCT in the North American phase 3 fingolimod trial for relapsing-remitting multiple sclerosis. J
6. Zein G, Berta A, Foster CS. Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm. 2004;12(2):137-42.
7. Zierhut M, Foster CS. Multiple sclerosis, sarcoidosis and other diseases in patients with pars planitis. Dev
8. Biousse V, Trichet C, Bloch-Michel E, Roullet E. Multiple sclerosis associated with uveitis in two large clinic-
based series. Neurology. 1999;52(1):179-81.
9. Le Scanff J, Seve P, Renoux C, Broussolle C, Confavreux C, Vukusic S. Uveitis associated with multiple sclerosis.
Mult Scler. 2008;14(3):415-7.
10. Messenger W, Hildebrandt L, Mackensen F, Suhler E, Becker M, Rosenbaum JT. Characterisation of uveitis in
association with multiple sclerosis. Br J Ophthalmol. 2015;99(2):205-9.
11. Shugaiv E, Tuzun E, Kurtuncu M, et al. Uveitis as a prognostic factor in multiple sclerosis. Mult Scler.
12. Olsen TG, Frederiksen J. The association between multiple sclerosis and uveitis. Surv Ophthalmol.